JP2023551068A5 - - Google Patents

Info

Publication number
JP2023551068A5
JP2023551068A5 JP2023552148A JP2023552148A JP2023551068A5 JP 2023551068 A5 JP2023551068 A5 JP 2023551068A5 JP 2023552148 A JP2023552148 A JP 2023552148A JP 2023552148 A JP2023552148 A JP 2023552148A JP 2023551068 A5 JP2023551068 A5 JP 2023551068A5
Authority
JP
Japan
Prior art keywords
amino acid
disease
acid sequence
protein
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023552148A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023551068A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/058285 external-priority patent/WO2022099033A1/en
Publication of JP2023551068A publication Critical patent/JP2023551068A/ja
Publication of JP2023551068A5 publication Critical patent/JP2023551068A5/ja
Pending legal-status Critical Current

Links

JP2023552148A 2020-11-06 2021-11-05 サイトゾルタンパク質ターゲティング操作脱ユビキチン化酵素およびその使用方法 Pending JP2023551068A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063110622P 2020-11-06 2020-11-06
US63/110,622 2020-11-06
PCT/US2021/058285 WO2022099033A1 (en) 2020-11-06 2021-11-05 Cytosolic protein targeting engineered deubiquitinases and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2023551068A JP2023551068A (ja) 2023-12-06
JP2023551068A5 true JP2023551068A5 (enExample) 2024-11-11

Family

ID=81456819

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023552148A Pending JP2023551068A (ja) 2020-11-06 2021-11-05 サイトゾルタンパク質ターゲティング操作脱ユビキチン化酵素およびその使用方法

Country Status (7)

Country Link
US (1) US20240025984A1 (enExample)
EP (1) EP4240752A4 (enExample)
JP (1) JP2023551068A (enExample)
CN (1) CN116806223A (enExample)
AU (1) AU2021373818A1 (enExample)
CA (1) CA3200980A1 (enExample)
WO (1) WO2022099033A1 (enExample)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2297325A4 (en) * 2008-05-29 2011-10-05 Chum METHODS OF STRATIFICATION, PROGNOSIS AND DIAGNOSIS OF SCHIZOPHRENIA, MUTANT NUCLEIC ACID MOLECULES AND POLYPEPTIDES
CN118995678A (zh) * 2017-11-06 2024-11-22 纽约市哥伦比亚大学理事会 使用工程化的去泛素化酶探测泛素依赖性细胞过程的组合物和方法
US20210079366A1 (en) * 2017-12-22 2021-03-18 The Broad Institute, Inc. Cas12a systems, methods, and compositions for targeted rna base editing
US20220160890A1 (en) * 2019-02-21 2022-05-26 Locki Therapeutics Limited Survival-targeting chimeric (surtac) molecules
EP4240751A4 (en) * 2020-11-06 2024-10-23 Flux Therapeutics, Inc. MODIFIED DESUBIQUITINASES TARGETING NUCLEAR PROTEINS AND METHODS OF USE THEREOF

Similar Documents

Publication Publication Date Title
US20250002604A1 (en) Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
US20230114070A1 (en) Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
US20230277625A1 (en) Interleukin-18 variants and methods of use
KR102182800B1 (ko) 아지도 기를 포함하는 변형된 아미노산
US20230095053A1 (en) Antibodies comprising site-specific glutamine tags, methods of their preparation and methods of their use
JP2023549761A5 (enExample)
JP2023551068A5 (enExample)
JP2023548973A5 (enExample)
JP2023549167A5 (enExample)
EP4183803A1 (en) Fusion protein comprising ige fc receptor alpha subunit extracellular domain and anti-il-4r antibody, and use thereof
EP4520768A1 (en) Vhh-ch3 fusion proteins
RU2808563C2 (ru) МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ИЛИ ЕГО АНТИГЕНСВЯЗЫВАЮЩИЙ ФРАГМЕНТ, КОТОРОЕ СПЕЦИФИЧЕСКИ СВЯЗЫВАЕТСЯ С IL-4Rα, И ЕГО ПРИМЕНЕНИЕ
HK1203518B (en) Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use